Cargando…

Temporal Trends in Lipoprotein(a) Concentrations: The Atherosclerosis Risk in Communities Study

BACKGROUND: Plasma lipoprotein(a) (Lp[a]) concentrations are primarily determined by genetic factors and are believed to remain stable throughout life. However, data are scarce on longitudinal trends in Lp(a) concentrations over time. Therefore, it is unclear whether measurement of Lp(a) once in a p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deshotels, Matthew R., Sun, Caroline, Nambi, Vijay, Virani, Salim S., Matsushita, Kunihiro, Yu, Bing, Ballantyne, Christie M., Hoogeveen, Ron C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673625/ https://www.ncbi.nlm.nih.gov/pubmed/36285784 http://dx.doi.org/10.1161/JAHA.122.026762

Ejemplares similares

Associations of Lipoprotein(a) Levels With Incident Atrial Fibrillation and Ischemic Stroke: The ARIC (Atherosclerosis Risk in Communities) Study
por: Aronis, Konstantinos N., et al.
Publicado: (2017)

Postprandial lipemia and the risk of coronary heart disease and stroke: the Atherosclerosis Risk in Communities (ARIC) Study
por: Kats, Dmitry, et al.
Publicado: (2017)

Causal Role of Alcohol Consumption in an Improved Lipid Profile: The Atherosclerosis Risk in Communities (ARIC) Study
por: Vu, Khanh N., et al.
Publicado: (2016)

Cardiac Biomarkers and Subsequent Risk of Hospitalization With Bleeding in the Community: Atherosclerosis Risk in Communities Study
por: Mathews, Lena, et al.
Publicado: (2020)

Growth Differentiation Factor 15 and Risk of Bleeding Events: The Atherosclerosis Risk in Communities Study
por: Mathews, Lena, et al.
Publicado: (2023)

Lipoprotein(a) and Subclinical Vascular and Valvular Calcification on Cardiac Computed Tomography: The Atherosclerosis Risk in Communities Study
por: Obisesan, Olufunmilayo H., et al.
Publicado: (2022)

Acute Tubular Injury in a Patient on a Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor
por: Pickett, June K., et al.
Publicado: (2020)

Levels and Change in Galectin‐3 and Association With Cardiovascular Events: The ARIC Study
por: Aguilar, David, et al.
Publicado: (2020)

Diabetes Medication Use and Blood Lactate Level among Participants with Type 2 Diabetes: The Atherosclerosis Risk in Communities Carotid MRI Study
por: Mongraw-Chaffin, Morgana L., et al.
Publicado: (2012)

Prognostic implications of myocardial fibrosis and troponin levels measured by a highly sensitive assay in non-ischemic cardiomyopathy
por: Yang, Eric Y, et al.
Publicado: (2016)

Association of blood lactate with type 2 diabetes: the Atherosclerosis Risk in Communities Carotid MRI Study
por: Crawford, Stephen O, et al.
Publicado: (2010)

Temporal Trends in Characteristics and Outcomes Associated With In‐Hospital Cardiac Arrest: A 20‐Year Analysis (1999–2018)
por: Wu, Lingling, et al.
Publicado: (2021)

Novel Risk Factors and the Prediction of Type 2 Diabetes in the Atherosclerosis Risk in Communities (ARIC) Study
por: Raynor, L.A., et al.
Publicado: (2013)

Factors Associated With Enhanced Low‐Density Lipoprotein Cholesterol Lowering With Bempedoic Acid
por: Ballantyne, Christie M., et al.
Publicado: (2022)

Racial Differences in Association of Elevated Interleukin-18 Levels With Type 2 Diabetes: The Atherosclerosis Risk in Communities Study
por: Negi, Smita I., et al.
Publicado: (2012)

APOL1 Risk Alleles, Cardiac Markers, and Risk of ESKD in African Americans: The Atherosclerosis Risk in Communities Study
por: Surapaneni, Aditya L., et al.
Publicado: (2020)

Galectin‐3 and venous thromboembolism incidence: the Atherosclerosis Risk in Communities (ARIC) Study
por: Fashanu, Oluwaseun E., et al.
Publicado: (2017)

A dataset to assess providers׳ knowledge and attitudes towards the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline
por: Pokharel, Yashashwi, et al.
Publicado: (2016)

Ultrasound in Cardiovascular Risk Prediction: Don't Forget the Plaque!
por: Nambi, Vijay, et al.
Publicado: (2013)

Identifying Differences: A Key Step in Precision Cardiovascular Disease Prevention
por: Al Rifai, Mahmoud, et al.
Publicado: (2022)

Lipoprotein (a): Recent Updates on a Unique Lipoprotein
por: Saeed, Anum, et al.
Publicado: (2021)

E-cigarette Use and Risk Behaviors among Lesbian, Gay, Bisexual, and Transgender Adults: The Behavioral Risk Factor Surveillance System (BRFSS) Survey
por: Al Rifai, Mahmoud, et al.
Publicado: (2020)

High-Sensitivity Cardiac Troponin I and T for Cardiovascular Risk Stratification in Adults With Diabetes
por: Tang, Olive, et al.
Publicado: (2020)

Performance of High-Sensitivity Cardiac Troponin Assays to Reflect Comorbidity Burden and Improve Mortality Risk Stratification in Older Adults With Diabetes
por: Tang, Olive, et al.
Publicado: (2020)

Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis
por: Chen, Suet Nee, et al.
Publicado: (2009)

Immune Response to Lipoproteins in Atherosclerosis
por: Samson, Sonia, et al.
Publicado: (2012)

Racial Differences in Circulating Natriuretic Peptide Levels: The Atherosclerosis Risk in Communities Study
por: Gupta, Deepak K, et al.
Publicado: (2015)

Relationship of extracellular volume assessed on cardiac magnetic resonance and serum cardiac troponins and natriuretic peptides with heart failure outcomes
por: Yang, Eric Y., et al.
Publicado: (2019)

Lactate and Risk of Incident Diabetes in a Case-Cohort of the Atherosclerosis Risk in Communities (ARIC) Study
por: Juraschek, Stephen P., et al.
Publicado: (2013)

Central and peripheral pulse wave velocity and subclinical myocardial stress and damage in older adults
por: Liu, Shuiqing, et al.
Publicado: (2019)

Association of High‐Density Lipoprotein‐Cholesterol Versus Apolipoprotein A‐I With Risk of Coronary Heart Disease: The European Prospective Investigation Into Cancer‐Norfolk Prospective Population Study, the Atherosclerosis Risk in Communities Study, and the Women's Health Study
por: van Capelleveen, Julian C., et al.
Publicado: (2017)

PCSK9 Inhibitors in the Management of Cardiovascular Risk: A Practical Guidance
por: Jia, Xiaoming, et al.
Publicado: (2022)

Lipids and Lipoproteins in Atherosclerosis
por: Chroni, Angeliki, et al.
Publicado: (2011)

Lipids and Lipoproteins in Atherosclerosis
por: Bezsonov, Evgeny, et al.
Publicado: (2023)

Obesity and Subtypes of Incident Cardiovascular Disease
por: Ndumele, Chiadi E., et al.
Publicado: (2016)

Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry
por: Basra, Sukhdeep S., et al.
Publicado: (2018)

Relationship between Concentration Difference of Different Density Lipoproteins and Shear Stress in Atherosclerosis
por: Meng, Wei, et al.
Publicado: (2012)

The Impact of Rapid Weight Loss on Oxidative Stress Markers and the Expression of the Metabolic Syndrome in Obese Individuals
por: Tumova, Eva, et al.
Publicado: (2013)

Endothelial Transcytosis of Lipoproteins in Atherosclerosis
por: Zhang, Xinbo, et al.
Publicado: (2018)

Carotid Atherosclerosis, Ultrasound and Lipoproteins
por: Iannuzzi, Arcangelo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sqk7d4nri09i6jnfkjkhcn34ul